Outbreak of vancomycin-resistant Enterococcus faecium ST1133 in paediatric patients with acute lymphoblastic

Thaís Muniz Vasconcelos1, Dany Mesa1, Luiza Souza Rodrigues2

  • 1Faculdades Pequeno Príncipe (FPP), Curitiba, Paraná, Brazil; Instituto de Pesquisa Pelé Pequeno Príncipe (IPPPP), Curitiba, Paraná, Brazil.

Abstract

Insights

An outbreak of vancomycin-resistant Enterococcus faecium (VREfm) in children with leukemia was investigated. Whole-genome sequencing identified the ST117 lineage, highlighting the need for antimicrobial stewardship to control VREfm spread in vulnerable patients.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Vancomycin-resistant Enterococcus faecium (VREfm) poses a significant threat, particularly in immunocompromised populations.
  • Paediatric patients with hematological malignancies are at high risk for VREfm colonization and infection.

Purpose of the Study:

  • To investigate an outbreak of VREfm in paediatric patients at Hospital Pequeno Príncipe.
  • To characterize the genetic makeup and resistance mechanisms of the VREfm strains involved.

Main Methods:

  • Whole-genome sequencing (WGS) was employed to analyze VREfm isolates.
  • Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) for species identification.
  • Antimicrobial susceptibility testing (MIC) and in silico multilocus sequence typing (MLST) were performed.

Main Results:

  • Five VREfm isolates from two paediatric patients with acute lymphoblastic leukemia were identified.
  • All isolates exhibited high-level vancomycin resistance (MIC ≥256 mg/L).
  • WGS revealed the presence of plasmids, insertion sequences, phages, and multiple resistance (vanA, ermB, aac(6 olyl)-aph(2 olyl), dfrG) and virulence genes (acm, efaAfm).
  • All isolates belonged to the ST117 lineage (ST1133 via novel MLST), a known epidemic strain.

Conclusions:

  • The ST117 VREfm lineage is circulating among paediatric patients, raising significant concerns.
  • Effective management requires the development of new antimicrobial agents and robust antimicrobial stewardship programs.
  • Controlling VREfm spread is crucial, especially in oncohematological patients.

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...